| Literature DB >> 29331391 |
Elżbieta Sokół1, Hanna Kędzierska1, Alicja Czubaty2, Beata Rybicka1, Katarzyna Rodzik1, Zbigniew Tański3, Joanna Bogusławska4, Agnieszka Piekiełko-Witkowska5.
Abstract
SRSF1, SRSF2 and hnRNP A1 are splicing factors that regulate the expression of oncogenes and tumor suppressors. SRSF1 and SRSF2 contribute to the carcinogenesis in the kidney. Despite their importance, the mechanisms regulating their expression in cancer are not entirely understood. Here, we investigated the microRNA-mediated regulation of SRSF1, SRSF2 and hnRNP A1 in renal cancer. The expression of microRNAs predicted to target SRSF1, SRSF2 and hnRNP A1 was disturbed in renal tumors compared with controls. Using qPCR, Western blot/ICC and luciferase reporter system assays we identified microRNAs that contribute to the regulation of expression of SRSF1 (miR-10b-5p, miR-203a-3p), SRSF2 (miR-183-5p, miR-200c-3p), and hnRNP A1 (miR-135a-5p, miR-149-5p). Silencing of SRSF1 and SRSF2 enhanced the expression of their targeting microRNAs. miR-183-5p and miR-200c-3p affected the expression of SRSF2-target genes, TNFRSF1B, TNFRSF9, CRADD and TP53. 3'UTR variants of SRSF1 and SRSF2 differed by the presence of miRNA-binding sites. In conclusion, we identified a group of microRNAs that contribute to the regulation of expression of SRSF1, SRSF2 and hnRNP A1. The microRNAs targeting SRSF1 and SRSF2 are involved in a regulatory feedback loop. microRNAs miR-183-5p and miR-200c-3p that target SRSF2, affect the expression of genes involved in apoptotic regulation.Entities:
Keywords: 3′UTR; Renal cancer; SRSF1; SRSF2; hnRNP A1; microRNA
Mesh:
Substances:
Year: 2018 PMID: 29331391 DOI: 10.1016/j.yexcr.2018.01.009
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905